Missouri regulators have raised the allowable limit for vitamin E acetate in regulated marijuana products from 0.2 parts per million to 5 parts per million, sparking concern from stakeholders including the state’s chapter of the National Organization for the Reform of Marijuana Laws.
While New Yorkers sit at home and patiently wait for the adult-use market to get up and running, the gray market is flourishing.
A health emergency in which dozens of people died and 2,600-plus were admitted to hospitals immediately took its toll on vape-related companies, and all signs pointed to an additive, vitamin E acetate, which officials found in some of the implicated THC vaping products.
The U.S. cannabis industry experienced some momentous moves forward on the legalization front in 2019, but it also faced significant obstacles that reflected how the licensed marijuana sector is continuing to mature and why it cannot always expect boom times and unfettered growth.
The vaping crisis hasn’t dimmed Americans’ support to legalize marijuana, according to a Gallup poll released Wednesday.
The rash of headlines linking deadly respiratory illnesses to vaping has had little impact on the popularity of such products.
This report takes a closer look at the vape segment of cannabis and provides a framework to assess the downside risk and upside potential of stocks with significant exposure to the sector.
Fallout from the vape crisis continues as state and federal regulators take more action, certain retailers pull product from shelves, and tobacco giant Philip Morris walked away from a merger with Altria.
In this Executive Webinar on Sept. 26 at 2 p.m. ET, CEO Jessica Billingsley will join Investor Intelligence Analyst Mike Regan to discuss Akerna’s outlook and the role technology can play in addressing the current vape crisis.
